Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
WCLC 2018Durvalumab New Standard in Stage III Unresectable Lung CancerNow with data showing an overall survival advantage, the immunotherpy sets new standard of care in stage III unresectable lung cancer following concurrent chemotherapy and radiotherapy.
Lung Cancer Community: 'This Is Our Fight'At the premier gathering of the lung cancer community, the first plenary session speaker insisted: 'We cannot deal with lung
cancer and not fight against tobacco.
Medscape Medical News, Oct 17, 2017
Lung Cancer May Grow Faster During ImmunotherapyA retrospective analysis from France found that 14% of patients with advanced lung cancer showed an acceleration of tumor
growth while receiving immunotherapy.